| Case non-case studies: Principle, methods, bias and interpretation |
23 |
| Pharmacovigilance - The next chapter |
11 |
| What is pharmacoepidemiology? Definition, methods, interest and clinical applications |
10 |
| French administrative health care database (SNDS): The value of its enrichment |
7 |
| Interest of large electronic health care databases in addictovigilance: Lessons from 15 years of pharmacoepidemiological contribution |
7 |
| Pregnancy outcome following in utero exposure to azathioprine: A French comparative observational study |
7 |
| Chronic use of proton pump inhibitors, adverse events and potential biological mechanisms: A translational analysis |
6 |
| The limitations of observation studies for decision making regarding drugs efficacy and safety |
6 |
| Pharmacoepidemiology of non-steroidal anti-inflammatory drugs |
6 |
| From psychoactive medicines to addictovigilance in French Public Health Code (1990-2017) |
6 |
| Off-label and unlicensed drug use in children population |
6 |
| Pharmaceutical cognitive doping in students: A chimeric way to get-a-head? |
4 |
| The value of a health insurance database to conduct pharmacoepidemiological studies in oncology |
4 |
| How the new European data protection regulation affects clinical research and recommendations? |
4 |
| Proton pump inhibitors prescriptions in France: Main trends from 2006 to 2016 on French health insurance database |
4 |
| Improve the benefit / risk balance of methadone by respecting its pharmacological specificities |
4 |
| Birth defects in children of men exposed in utero to diethylstilbestrol (DES) |
3 |
| The French Levothyrox (R) crisis: We did the best we could but . . . |
3 |
| A history of pharmacoepidemiology |
3 |
| How to strengthen the presence of patients in health technology assessments conducted by the health authorities |
3 |
| Case-non case studies: Principles, methods, bias and interpretation |
3 |
| Cutaneous pigmentation related to intravenous iron extravasation: Analysis from the French pharmacovigilance database |
3 |
| Effectiveness, therapeutic maintenance and reasons for stopping tocilizumab (TCZ): A retrospective and monocentric study in 88 patients followed for rheumatoid arthritis (RA) at the Reims university hospital |
2 |
| Collection of human biological samples for research purpose: Key challenges and patients' perspectives |
2 |
| Pharmacological management of neuropathic pain |
2 |
| Pharmacoepidemiology in pregnancy |
2 |
| Pharmacoepidemiology of statins |
2 |
| Interest and challenges of pharmacoepidemiology for the study of drugs used in diabetes |
2 |
| Interest of pharmacoepidemiology in pharmacovigilance: Post-authorization safety studies in regulatory pharmacovigilance activity |
2 |
| Contribution of genomics in the medicine of tomorrow, clinical applications and issues |
2 |
| New European medical device regulation: How the French ecosystem should seize the opportunity of the EUDAMED and the UDI system, while overcoming the constraints thereof |
2 |
| Management of medication errors in general medical practice: Study in a pluriprofessionnal health care center |
2 |
| Satisfaction of a pharmacovigilance declaration support network in general practice |
2 |
| Interest of take-home naloxone for opioid overdose |
2 |
| ISO 9001certification of a quality management system in a clinical investigation center |
2 |
| Artificial intelligence: Which services, which applications, which results and which development today in clinical research? Which impact on the quality of care? Which recommendations? |
2 |
| Monitoring of drug misuse or potential misuse in a nationwide healthcare insurance database: A cross-sectional study in France |
2 |
| Pantoprazole reduces serum ferritin in patients with thalassemia major and intermedia: A randomized, controlled study |
2 |
| Alitretinoin (Toctino (R)): A French follow-up study of harmacovigilance |
2 |
| Bullous fixed drug eruption: A potential diagnostic pitfall: a study of 18 cases |
2 |
| Antidepressive agents and hyponatremia: A literature review and a case/non-case study in the French Pharmacovigilance database |
2 |
| Adverse reactions related to brentuximab vedotin use: A real-life retrospective study |
2 |
| Benzodiazepines, cognitive decline and dementia: A review of causality criteria from published observational studies |
2 |
| Pharmacovigilance in pediatrics |
1 |
| Pharmacogenetics and application in pediatrics |
1 |
| Use of available clinical evidence to extrapolate drug effects from adults to children |
1 |
| Use of French healthcare insurance databases in pediatric pharmacoepidemiology |
1 |
| Identification of abuse/dependence cases by the French addictovigilance network (FAN): A pilot study of the addictovigilance center and the psychotherapeutic center of Nancy |
1 |
| Illogical association nalmefene and opioids: Analysis in the French pharmacovigilance database |
1 |
| Is the collecting activity of regional pharmacovigilance centers influenced by regional demographic or health determinants? |
1 |
